Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Modern Health Portugal.

Isaiah House and Healthworks Pros, LLC Launch NJ HEAL: A New Medication-Assisted Treatment Initiative in East Orange, NJ
NJ HEAL addresses the urgent need for accessible, high-quality healthcare services for individuals struggling with opioids. EAST ORANGE, NJ, UNITED STATES, September 23, 2024 /EINPresswire.com/ -- Isaiah House, Inc., a nonprofit family shelter,...

At G7 Agriculture: Mediterranean Diet UNESCO Communities Present 10 Key Recommendations for Global Leaders
Mediterranean Diet: A sustainable model for the future—Preserve heritage, reduce waste, protect biodiversity. Promote slow tourism for community development. ITALY, September 28, 2024 /EINPresswire.com/ -- G7 Agriculture, Syracuse - During the...

Neurolixis Secures Orphan Medicinal Product Designation for NLX-112 as a Treatment for Spinocerebellar Ataxia
European Commission approves OMP Designation for NLX-112 (befiradol) following compelling results in studies funded by the US Dept of Defense. CASTRES, FRANCE, September 25, 2024 /EINPresswire.com/ -- Neurolixis Inc., a biopharmaceutical company...

EUR 200 million share buyback begins
Schiphol, July 1, 2025 - Aegon today begins a EUR 200 million share buyback that was announced on May 16, 2025. The share buyback is expected to be completed by December 15, 2025, barring unforeseen circumstances. Aegon has entered into an...

EUR 150 million share buyback completed
Schiphol, July 1, 2025 - Aegon today announces the completion of its EUR 150 million share buyback program that began on January 13, 2025. Between January 13, 2025, and June 30, 2025, 25,200,170 common shares were repurchased for a total amount of...

Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor
Press Release Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor Geneva, Switzerland – September 19, 2024 – STALICLA SA, a Swiss neuro precision biotech company dedicated to developing precision...

Announcement: International Conference on Young Women’s Breast Cancer and Health, October 29-30, 2024, Lisbon, Portugal
First of its kind global platform for sharing the latest medical advances and addressing the unique challenges faced by young women diagnosed with breast cancer DENVER, CO, UNITED STATES, September 17, 2024 /EINPresswire.com/ -- The Breast...

The Open Wing Alliance Releases Results Of Largest-Ever Global Investigation Into Industrial Egg Farms In 37 Countries
Investigation highlights documented overcrowding, unsanitary conditions, and potential public health concerns across international egg supply chains. NEW YORK, NY, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- The Open Wing Alliance, a...
![[Investment Promotion in East and North China] IPIM Promotes to Over 65 Technology and Health Enterprises, with Research and Co-operation Plans from Companies in Hangzhou and Shenyang](/images/pressrelease-small.png)
[Investment Promotion in East and North China] IPIM Promotes to Over 65 Technology and Health Enterprises, with Research and Co-operation Plans from Companies in Hangzhou and Shenyang
MACAU, October 4 - To support the appropriate diversification of Macao's economy, the Commerce and Investment Promotion Institute (IPIM) conducted investment promotion work in Hangzhou and Shenyang in late September, aiming to attract more...

Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress
SOUTH JORDAN, Utah, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that clinicians will present updates on two of its pivotal...

Tilray Medical Launches Redecan Cannabis Brand in Australia
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and...

Verde announces results of the 2025 Annual General Meeting of shareholders
SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd. (TSX: “NPK”) ("Verde” or the “Company”) held its Annual General Meeting of shareholders (the “Meeting”) on Monday, June 30, 2025, at 300 Prof. Antônio Aleixo, Lourdes Belo Horizonte,...

CARBIOS and Selenis announce strategic partnership to produce PETG issued from CARBIOS’ biorecycling technology for Cosmetic and Healthcare markets
Clermont-Ferrand (France), Tuesday 24 September 2024 (6pm CEST). - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and...

Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and...

Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize the Polish medical cannabis market with the most Innovative Cannabis-Based Solutions LISBON, PORTUGAL, August 29, 2024 /EINPresswire.com/ -- Cosma S.A., a leader in cannabis-based...

ARC Medical Inc. Continues Participation in Premier Life Science Summits and Conferences
Select Venues Provide Opportunities for ARC to Highlight its Innovative Pipeline of Medical Devices for the Prevention of Surgical Adhesions VANCOUVER, BRITISH COLUMBIA, CANADA, September 5, 2024 /EINPresswire.com/ -- ARC Medical Inc. (ARC) is...

Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2
New pre-clinical data demonstrates that the novel EVX-B2 mRNA vaccine candidate triggers a targeted immune response The specific immune response leads to the elimination of the gonorrhea bacteria The data confirm that Evaxion’s AI-Immunology™...

Pierre Lemire, CEO of Kent Imaging, to Present at LSI Europe in Portugal this September
Canadian MedTech innovator, Pierre Lemire, will be at LSI Europe 2024 to present the Snapshot Platform of light-based imaging technology. CALGARY, ALBERTA, CANADA, September 10, 2024 /EINPresswire.com/ -- Kent Imaging, a leading medical device...

Choroideremia Research Foundation Announces Six New Global Grants to Accelerate Vision Science
CRF awards six global grants to advance CHM research, spanning AI, gene editing, and more—driving progress toward treatments for this rare retinal disease. SPRINGFIELD, MA, UNITED STATES, June 6, 2025 /EINPresswire.com/ -- The Choroideremia...

Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that...